Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Tapimmune Inc (TPIV)

Tapimmune Inc (TPIV)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 114,341
  • Shares Outstanding, K 13,710
  • Annual Sales, $ 0 K
  • Annual Income, $ -10,980 K
  • 60-Month Beta -0.41
  • Price/Sales 544.48
  • Price/Cash Flow N/A
  • Price/Book 21.52
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.35
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/21/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/16
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.30 +14.25%
on 10/12/18
10.60 -21.32%
on 09/25/18
-1.23 (-12.85%)
since 09/17/18
3-Month
6.53 +27.72%
on 07/26/18
10.60 -21.32%
on 09/25/18
-1.55 (-15.67%)
since 07/17/18
52-Week
2.58 +223.26%
on 04/23/18
13.55 -38.45%
on 06/19/18
+5.18 (+163.92%)
since 10/17/17

Most Recent Stories

More News
CBD Brands, Inc. Appoints Dr. Glynn Wilson to CBD Board of Directors

Today CBD Brands, a cutting-edge wellness brand dedicated to exploring the multiple therapeutic and medical uses of cannabidiol (CBD) via a multitude of convenient products, announced that it has appointed...

TPIV : 8.34 (+0.60%)
Genprex Appoints John N. Bonfiglio, PhD, to Board of Directors

Genprex, Inc. (NASDAQ: GNPX) a clinical-stage gene therapy company developing a new approach to treating cancer based upon a novel proprietary technology platform, announced...

OGEN : 0.47 (unch)
TPIV : 8.34 (+0.60%)
GNPX : 1.09 (+1.87%)
FinancialBuzz.com Exclusive Interview With Chairman and CEO Denis Corin of Q BioMed Inc. Live From Times Square in New York City

www.FinancialBuzz.com, a respected source in the financial news media space located on Wall Street, today announces an exclusive video interview with Q Biomed Inc. (OTCQB: QBIO) Chairman and CEO, Denis...

QBIO : 1.2200 (-3.17%)
TPIV : 8.34 (+0.60%)
FinancialBuzz.com Exclusive Interview With Chairman and CEO Denis Corin of Q BioMed Inc. Live From Times Square in New York City

www.FinancialBuzz.com, a respected source in the financial news media space located on Wall Street, today announces an exclusive video interview with Q Biomed Inc. (OTCQB: QBIO) Chairman and CEO, Denis...

QBIO : 1.2200 (-3.17%)
TPIV : 8.34 (+0.60%)
Trade TPIV with:

Business Summary

TapImmune Inc. is an immunotherapy company. It specializes in the development of innovative peptide and gene-based immunotherapeutics and vaccines for the treatment of oncology and infectious disease. The Company also develops therapies for infectious diseases, autoimmune disorders, and transplant tissue...

See More

Key Turning Points

2nd Resistance Point 8.64
1st Resistance Point 8.49
Last Price 8.34
1st Support Level 8.10
2nd Support Level 7.86

See More

52-Week High 13.55
Fibonacci 61.8% 9.36
Last Price 8.34
Fibonacci 50% 8.07
Fibonacci 38.2% 6.77
52-Week Low 2.58

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar